Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation

BMC Pharmacology

Volumn 12, Issue , 2012, Pages

  Aaltonen, Niina ^a   Lehtonen, Marko ^a   Varonen, Katri ^a   Goterris, Gemma A ^a   Laitinen, Jarmo T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM FLUORIDE; ENZYME INHIBITOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MAGNESIUM ION; N ETHYLMALEIMIDE; PHOSPHATASE; PROPRANOLOL; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; RAT; TISSUE SECTION;

ALUMINUM COMPOUNDS; ANIMALS; BRAIN; ENZYME INHIBITORS; FLUORIDES; LYSOPHOSPHOLIPIDS; MALE; PHOSPHATIDATE PHOSPHATASE; PROPRANOLOL; RATS; RATS, WISTAR; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; VANADATES;

EID: 84861974222     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-12-7     Document Type: Article

References (55)

1. Birgbauer E, Chun J. New developments in the biological functions of lysophospholipids. Cell Mol Life Sci 2006, 63:2695-2701.
2. Moolenaar WH, van Meeteren LA, Giepmans BN. The ins and outs of lysophosphatidic acid signaling. BioEssays 2004, 26:870-881.
3. Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002, 1582:204-215.
4. Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003, 3:582-591.
5. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 2010, 50:157-186.
6. Ishii S, Noguchi K, Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 2009, 89:57-65.
7. zu Heringdorf D. Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 2007, 1768:923-940.
8. Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature. Pharmacol Rev 2010, 62:579-587.
9. Aaltonen N, Laitinen JT, Lehtonen M. Quantification of lysophosphatidic acids in rat brain tissue by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:1145-1152.
10. Nakane S, Oka S, Arai S, Waku K, Ishima Y, Tokumura A, Sugiura T. 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. Arch Biochem Biophys 2002, 402:51-58.
11. Sugiura T, Nakane S, Kishimoto S, Waku K, Yoshioka Y, Tokumura A, Hanahan DJ. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. Biochim Biophys Acta 1999, 1440:194-204.
12. van Meeteren LA, Moolenaar WH. Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 2007, 46:145-160.
13. Aoki J. Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol 2004, 15:477-489.
14. Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 2008, 1781:513-518.
15. Tigyi G, Parrill AL. Molecular mechanisms of lysophosphatidic acid action. Prog Lipid Res 2003, 42:498-526.
16. Brindley DN, Pilquil C. Lipid phosphate phosphatases and signaling. J Lipid Res 2009, 50(Suppl):225-230.
17. Pyne S, Kong KC, Darroch PI. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. Semin Cell Dev Biol 2004, 15:491-501.
18. Sigal YJ, McDermott MI, Morris AJ. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem J 2005, 387:281-293.
19. Kai M, Wada I, Imai S, Sakane F, Kanoh H. Cloning and characterization of two human isozymes of Mg2 + -independent phosphatidic acid phosphatase. J Biol Chem 1997, 272:24572-24578.
20. Roberts R, Sciorra VA, Morris AJ. Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform. J Biol Chem 1998, 273:22059-22067.
21. Waggoner DW, Gomez-Munoz A, Dewald J, Brindley DN. Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate. J Biol Chem 1996, 271:16506-16509.
22. Hooks SB, Ragan SP, Lynch KR. Identification of a novel human phosphatidic acid phosphatase type 2 isoform. FEBS Lett 1998, 427:188-192.
23. Jamal Z, Martin A, Gomez-Munoz A, Brindley DN. Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J Biol Chem 1991, 266:2988-2996.
24. Laitinen JT. [35 S]GTPgammaS autoradiography: A powerful functional approach with expanding potential for neuropharmacological studies on receptors coupled to Gi family of G proteins. Curr Neuropharmacol 2004, 2:191-206.
25. Sovago J, Dupuis DS, Gulyas B, Hall H. An overview on functional receptor autoradiography using [35 S]GTPgammaS. Brain Res Rev 2001, 38:149-164.
26. Aaltonen N, Palomaki VA, Lecklin A, Laitinen JT. Neuroanatomical mapping of juvenile rat brain regions with prominent basal signal in [35 S]GTPγS autoradiography. J Chem Neuroanat 2008, 35:233-241.
27. Laitinen JT. Selective detection of adenosine A1 receptor-dependent G-protein activity in basal and stimulated conditions of rat brain [35 S]guanosine 5'-(gamma-thio)triphosphate autoradiography. Neuroscience 1999, 90:1265-1279.
28. Palomaki VA, Laitinen JT. The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections. Br J Pharmacol 2006, 147:596-606.
29. Waeber C, Chiu ML. In vitro autoradiographic visualization of guanosine-5'-O-(3-[35 S]thio)triphosphate binding stimulated by sphingosine 1-phosphate and lysophosphatidic acid. J Neurochem 1999, 73:1212-1221.
30. Allard J, Barron S, Diaz J, Lubetzki C, Zalc B, Schwartz JC, Sokoloff P. A rat G protein-coupled receptor selectively expressed in myelin-forming cells. Eur J Neurosci 1998, 10:1045-1053.
31. Cervera P, Tirard M, Barron S, Allard J, Trottier S, Lacombe J, Daumas-Duport C, Sokoloff P. Immunohistological localization of the myelinating cell-specific receptor LP(A1). Glia 2002, 38:126-136.
32. Handford EJ, Smith D, Hewson L, McAllister G, Beer MS. Edg2 receptor distribution in adult rat brain. NeuroReport 2001, 12:757-760.
33. Weiner JA, Hecht JH, Chun J. Lysophosphatidic acid receptor gene vzg-1/lpA1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J Comp Neurol 1998, 398:587-598.
34. Palomaki VA, Lehtonen M, Savinainen JR, Laitinen JT. Visualization of 2-arachidonoylglycerol accumulation and cannabinoid CB1 receptor activity in rat brain cryosections by functional autoradiography. J Neurochem 2007, 101:972-981.
35. Simon MF, Rey A, Castan-Laurel I, Gres S, Sibrac D, Valet P, Saulnier-Blache JS. Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production. J Biol Chem 2002, 277:23131-23136.
36. Holinstat M, Voss B, Bilodeau ML, Hamm HE. Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway. Mol Pharmacol 2007, 71:686-694.
37. McDermott MI, Sigal YJ, Crump JS, Morris AJ. Enzymatic analysis of lipid phosphate phosphatases. Methods 2006, 39:169-179.
38. Li L. The biochemistry and physiology of metallic fluoride: action, mechanism, and implications. Crit Rev Oral Biol Med 2003, 14:100-114.
39. Saario SM, Savinainen JR, Laitinen JT, Järvinen T, Niemi R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 2004, 67:1381-1387.
40. Blankman JL, Simon GM, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 2007, 14:1347-1356.
41. Savinainen JR, Saario SM, Laitinen JT. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol (Oxf) 2012, 204:267-276.
42. Savinainen JR, Yoshino M, Minkkilä A, Nevalainen T, Laitinen JT. Characterization of binding properties of monoglyceride lipase inhibitors by a versatile fluorescence-based technique. Anal Biochem 2010, 399:132-134.
43. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, FJ P, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 2009, 5:37-44.
44. Zhang N, Sundberg JP, Gridley T. Mice mutant for Ppap2c, a homolog of the germ cell migration regulator wunen, are viable and fertile. Genesis 2000, 27:137-140.
45. Escalante-Alcalde D, Hernandez L, Le Stunff H, Maeda R, Lee HS, Cheng G, Sciorra VA, Daar I, Spiegel S, Morris AJ, Stewart CL. The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development 2003, 130:4623-4637.
46. Tomsig JL, Snyder AH, Berdyshev EV, Skobeleva A, Mataya C, Natarajan V, Brindley DN, Lynch KR. Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Biochem J 2009, 419:611-618.
47. Sánchez-Sánchez R, Morales-Lázaro SL, Baizabal JM, Sunkara M, Morris AJ, Escalante-Alcalde D. Lack of lipid phosphate phosphatase-3 in embryonic stem cells compromises neuronal differentiation and neurite outgrowth. Dev Dyn 2012, 241:953-964.
48. English D, Cui Y, Siddiqui R, Patterson C, Natarajan V, Brindley DN, Garcia JG. Induction of endothelial monolayer permeability by phosphatidate. J Cell Biochem 1999, 75:105-117.
49. Gaveglio VL, Pasquare SJ, Giusto NM. Metabolic pathways for the degradation of phosphatidic acid in isolated nuclei from cerebellar cells. Arch Biochem Biophys 2011, 507:271-280.
50. Baker RR, Chang HA. Metabolic path for the degradation of lysophosphatidic acid, an inhibitor of lysophosphatidylcholine lysophospholipase, in neuronal nuclei of cerebral cortex. Biochim Biophys Acta 2000, 1483:58-68.
51. Brauer AU, Nitsch R. Plasticity-related genes (PRGs/LRPs): a brain-specific class of lysophospholipid-modifying proteins. Biochim Biophys Acta 2008, 1781:595-600.
52. Trimbuch T, Beed P, Vogt J, Schuchmann S, Maier N, Kintscher M, Breustedt J, Schuelke M, Streu N, Kieselmann O, Brunk I, Laube G, Strauss U, Battefeld A, Wende H, Birchmeier C, Wiese S, Sendtner M, Kawabe H, Kishimoto-Suga M, Brose N, Baumgart J, Geist B, Aoki J, Savaskan NE, Bräuer AU, Chun J, Ninnemann O, Schmitz D, Nitsch R. Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell 2009, 138:1222-1235.
53. Esmann M. ATPase and phosphatase activity of Na+, K + -ATPase: molar and specific activity, protein determination. Methods Enzymol 1988, 156:105-115.
54. Vazquez MJ, Rodriguez B, Zapatero C, Tewb DG. Determination of phosphate in nanomolar range by an enzyme-coupling fluorescent method. Anal Biochem 2003, 320:292-298.
55. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.